65--NOI - Oxford Nanopore PromethION Flow Cells and cD

The National Institutes of Health, Office of the Director, intends to award a non-competitive, firm-fixed-price purchase order to Oxford Nanopore Technologies Inc. for PromethION flow cells and cDNA-PCR sequencing kits essential to support the National Institute on Aging’s Center for Alzheimer’s Disease and Related Dementias long-read RNA sequencing project on ROSMAP brain samples. This acquisition, issued as a combined synopsis/solicitation under FAR Subpart 12.6 and authorized under FAR 12.603 and 6.302-3(a)(2)(ii), is branded specifically to Oxford Nanopore’s proprietary products: FLO-PRO114M flow cells and SQK-LSK114-XL cDNA-PCR sequencing kits, which are required to maintain compatibility with the existing PromethION 48 sequencing infrastructure and to enable direct comparison with previously generated long-read whole-genome sequencing data. The solicitation, numbered 75N98026Q00477, was posted on May 29, 2026, with responses due by June 8, 2026, and is not a small business set-aside, operating under the simplified acquisition threshold. The contract is structured under commercial item acquisition rules, requiring offerors to submit pricing, technical capability documentation, and completed FAR 52.212-3 representations and certifications, including their Unique Entity Identifier and Taxpayer Identification Number, while maintaining an active SAM registration. The scope of work requires delivery of 72 flow cell packs and 48 cDNA-PCR sequencing kits, each kit supporting six reactions and requiring no more than 10 ng poly(A)+ RNA or 500 ng total RNA as starting material. All materials must be delivered in immediate usable and acceptable condition, marked with the contract number and contractor name, and shipped FOB destination under a six-month performance period from award date, running from June 9 to December 9, 2026. Invoicing must be submitted electronically via the IPP portal, must include a three-way match statement, and align precisely with the purchase order line items. Evaluation will focus solely on pass/fail gates related to manufacturer certification of salient product characteristics, with no numeric weighting assigned to potential factors such as past performance, technical capability, or warranty. No additional contract requirements beyond those specified are deemed necessary, and DPAS priorities do not apply. The NAICS